Jupiter Life Line Hospitals share price
NSE: JLHLBSE: 543980Healthcare ServicesSmall Cap
Jupiter Life Line Hospitals Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 2023 · Issue price ₹735
Last close ₹260.10up ₹3.35 (1.30%)BSE ₹260.70
Share price at the NSE close on 29 Oct 2026. Previous close ₹256.75.
29 Oct: open ₹258.00, high ₹261.50, low ₹252.00
52-week range of traded prices to 29 Oct 2026
₹233.40Low, 23 Oct 2026₹340.00High, 30 Jul 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹8,527 Cr604th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.23
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.08%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 11.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.36
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 1,21,02558.3% delivered
About Jupiter Life Line Hospitals
Jupiter Life Line Hospitals runs multi-speciality hospitals under the Jupiter brand in Thane, Pune, Indore and Dombivli, offering tertiary and quaternary care, the most complex levels of hospital treatment.1 Its specialities include organ transplants, oncology, orthopaedics, cardiology, paediatrics and neurology.2 It also runs the Fortune Park Lake City hotel in Thane, which it uses to promote medical tourism.1
The Thane hospital was established in 2007, followed by Baner in Pune in 2017 and Dombivli in 2026; the Indore hospital, Vishesh Jupiter, was acquired in 2020.3 Its material subsidiary (one large enough to need separate disclosure), Jupiter Hospital Projects Private Limited, is registered at the Vishesh Jupiter Hospital in Indore and is 96.56% owned by the company.4 It reports a single business segment, medical and healthcare services, in India.5 It had 3,002 employees in the year to Mar 2026.6
It was incorporated in 2002, with its registered office in Mulund, Mumbai.1 Its promoters include Ajay Thakker, its chairman, and Ankit Thakker, its CEO.7 The promoter and promoter group held 40.91% of its shares at the end of March 2026.89
Jupiter Life Line Hospitals key points
Results
- In the quarter to Sep 2026, consolidated total income (revenue plus operating other income, as the company presents it) was ₹456.5 crore against ₹393.6 crore a year earlier; EBITDA (earnings before interest, tax, depreciation and amortisation) was ₹106.9 crore against ₹92.2 crore.10
- Consolidated profit after tax was ₹56.4 crore in the quarter to Sep 2026 against ₹57.4 crore a year earlier, and ₹93.9 crore in the half year to Sep 2026 against ₹101.4 crore.1011
- In the half year to Sep 2026, consolidated total income was ₹867.5 crore against ₹746.6 crore a year earlier, and EBITDA ₹186.2 crore against ₹170.7 crore.11
- In the year to Mar 2026, consolidated total income was ₹1,499.8 crore against ₹1,302.4 crore a year earlier; EBITDA was ₹343.3 crore against ₹300.1 crore, and profit after tax ₹194.2 crore against ₹193.8 crore.1213
Payor mix
Hospitals and beds
- Beds by hospital: total capacity and beds in operation1617Operational bed capacity was 1,259 beds in the half year to Sep 2026, against 1,061 a year earlier.
Item year to Mar 2026 Thane 364 beds, 364 in operation Pune (Baner) 386 beds, 375 in operation Indore 431 beds, 309 in operation Dombivli 500 beds, 200 in operation - Average revenue per occupied bed per day (ARPOB) was ₹71,800 in the half year to Sep 2026, against ₹66,100 a year earlier; patients stayed 3.79 days on average, against 3.84.15
- In the year to Mar 2026, average bed occupancy was 61.2% including the new Dombivli hospital and 62.3% excluding it.18
Dombivli hospital
- The Dombivli hospital was inaugurated on 15 Feb 2026 after a ₹425 crore project investment and just over 25 months of construction. In its presentation of 23 Oct 2026, the company said about 200 beds were operational, with fit-outs complete for 100 more.1920
- The Dombivli hospital's EBITDA loss narrowed to ₹0.2 crore in the quarter to Sep 2026 from ₹9.5 crore in the quarter to Jun 2026, which the company attributes to higher medical admissions.21
- The company stated in its annual report for the year to Mar 2026 that it expects the Dombivli hospital to reach EBITDA breakeven by the end of its second year of operations.22
Expansion and capital spending
- In its presentation of 23 Oct 2026, the company said it is scaling bed capacity from 1,700 to 2,900, and put the average cost of its post-listing expansion of about 1,700 beds, built and planned, at about ₹1.5 crore a bed including land.23
- The company stated in its annual report for the year to Mar 2026 that its 500-bed Pune South hospital at Bibvewadi was on track for calendar year 2028.2425
- The company stated in its annual report for the year to Mar 2026 that it plans a 300-bed hospital at Mira-Bhayandar, with an estimated investment of ₹400 crore, expected in 2029.2627
- In its presentation of 23 Oct 2026, the company said its planned 400-bed hospital at Bandra Kurla Complex (BKC), Mumbai, was in the regulatory approval and planning stage.2829
Recent events
- On 23 Oct 2026 the board approved buying the land leased for the Pune South hospital, about 11,452.07 square metres at Bibvewadi, for ₹150 crore; a ₹50 crore deposit paid earlier is adjusted against the price.3031
- On 18 Oct 2026 the company signed a hypothecation agreement (a charge over its assets as security) with HDFC Bank for a ₹500 crore term loan to fund capital spending.3233
- On 15 May 2026 the board approved splitting each equity share of ₹10 face value into 5 shares of ₹2 each.34
- On 27 Mar 2026 the Mumbai Metropolitan Region Development Authority (MMRDA) accepted the company's tender for an 80-year lease of about 10,026.44 square metres at Bandra Kurla Complex for about ₹354 crore.35
Last updated
All 35 sources, each with its page
- 1. Annual report, 22 Jun 2026, page 73
- 2. Annual report, 22 Jun 2026, page 23
- 3. Annual report, 22 Jun 2026, page 8
- 4. Annual report, 22 Jun 2026, page 45
- 5. Annual report, 22 Jun 2026, page 103
- 6. Annual report, 22 Jun 2026, page 16
- 7. Annual report, 22 Jun 2026, page 50
- 8. Annual report, 22 Jun 2026, page 57
- 9. Annual report, 22 Jun 2026, page 57
- 10. Investor presentation, 23 Oct 2026, page 8
- 11. Investor presentation, 23 Oct 2026, page 8
- 12. Investor presentation, 23 Oct 2026, page 8
- 13. Annual report, 22 Jun 2026, page 25
- 14. Investor presentation, 23 Oct 2026, page 7
- 15. Investor presentation, 23 Oct 2026, page 7
- 16. Annual report, 22 Jun 2026, page 8
- 17. Investor presentation, 23 Oct 2026, page 7
- 18. Annual report, 22 Jun 2026, page 24
- 19. Annual report, 22 Jun 2026, page 23
- 20. Investor presentation, 23 Oct 2026, page 11
- 21. Investor presentation, 23 Oct 2026, page 5
- 22. Annual report, 22 Jun 2026, page 7
- 23. Investor presentation, 23 Oct 2026, page 11
- 24. Annual report, 22 Jun 2026, page 12
- 25. Annual report, 22 Jun 2026, page 73
- 26. Annual report, 22 Jun 2026, page 23
- 27. Annual report, 22 Jun 2026, page 5
- 28. Investor presentation, 23 Oct 2026, page 4
- 29. Investor presentation, 23 Oct 2026, page 11
- 30. Exchange filing, 23 Oct 2026, page 1
- 31. Investor presentation, 23 Oct 2026, page 4
- 32. Exchange filing, 19 Oct 2026, page 1
- 33. Exchange filing, 19 Oct 2026, page 2
- 34. Exchange filing, 15 May 2026, page 1
- 35. Exchange filing, 27 Mar 2026, page 1
Results
Consolidated; ₹ crore.Jupiter Life Line Hospitals quarterly results
- Revenue growth, 12 monthsRevenue growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- +16.3%
- Net profit growth, 12 monthsNet profit growth, 12 months. The last twelve months against the twelve before them. Left empty where the earlier figure was nought or a loss: growth out of a loss has no percentage.
- –
Quarter to Sep 2026, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹456 Crup 11.07%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent. Net profit in the glossary
- ₹56 Crup 50.24%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 12.3%
Revenue by quarter
Peak revenue ₹456 Cr, quarter to Sep 2026; lowest ₹321 Cr, quarter to Dec 2024
Net profit by quarter, a loss in red
| ₹ crore | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 321 | 327 | 353 | 394 | 365 | 388 | 411 | 456 |
| Net profit | 53 | 45 | 44 | 57 | 42 | 49 | 38 | 56 |
| Net margin | 16.4% | 13.7% | 12.5% | 14.6% | 11.6% | 12.6% | 9.1% | 12.3% |
Consolidated. The last eight quarters. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Year to Mar 2026, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹1,500 Crup 18.88%
- Net profitNet profit. The pill is the change in net profit against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹199 Crup 2.88%
- Net margin
- 13.3%
Revenue by year
Peak revenue ₹1,500 Cr, year to Mar 2026; lowest ₹1,070 Cr, year to Mar 2024
Net profit by year, a loss in red
| ₹ crore | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Revenue | 1,070 | 1,262 | 1,500 |
| Net profit | 177 | 194 | 199 |
| Net margin | 16.5% | 15.3% | 13.3% |
Consolidated. Years to March. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Business segments
In the year to Mar 2026 the company reports one business segment, Healthcare Services, which carries all its revenue.
Valuation
Today, against the company's own history. Not shown, P/E: a results filing in the last twelve months restated the quarters before it inside its year to date, so the four quarters as the company reported them do not add to a twelve-month profit; the ratio returns once the trailing year no longer holds a quarter from before the restatement.Jupiter Life Line Hospitals PE ratio and valuation
Price to book
At or below today's level on 1% of 726 trading days since Nov 2023.
LowestHighest
Its median7.00Industry median4.45
Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price. When a year's dividend goes ex later than the year before's, the yield reads zero for the days between; a run of under 60 such trading days is left out of the yield's medians and percentiles. The ex-date is the day from which a buyer of the share no longer gets the dividend.
At or below today's level on 84% of 744 trading days over the last 3 years.
LowestHighest
Its median0.07%Industry median0.25%
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −19.7% | +2.9% | −22.1% | 0.1% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth over 1 year is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.
Mutual fund holdings
30 funds disclosed a holding for Sep 2026. What they did in Sep 2026, against each fund's month before. 4 of the 10 funds that added or cut are index funds, ETFs or arbitrage funds: an index fund or ETF holds what its index holds, and an arbitrage fund holds the share against a sale of its future. 2 more funds filed their first portfolio on record, holding it.All 30 funds holding Jupiter Life Line Hospitals
- AddedAdded. Funds that held more shares than at the end of the month before.
- 9
- CutCut. Funds that held fewer shares than at the end of the month before.
- 1
- Held unchangedHeld unchanged. Funds that held the same number of shares as at the end of the month before.
- 18
- Sold outSold out. Funds that held it at the end of the month before and hold none at this month's end. Sold out in the glossary
- 6
| Fund | |||
|---|---|---|---|
 SBI Multicap FundSBI Mutual Fund | 1,93,53,082 | 2.09% | ₹490.8 Cr |
| SBI Healthcare Opportunities FundSBI Mutual Fund | 50,00,000 | 2.16% | ₹126.8 Cr |
 HDFC Multi Cap FundHDFC Mutual Fund | 42,55,577 | 0.55% | ₹107.9 Cr |
| HDFC Small Cap FundHDFC Mutual Fund | 42,47,850 | 0.26% | ₹107.7 Cr |
| HDFC Pharma and Healthcare FundHDFC Mutual Fund | 23,24,391 | 1.68% | ₹58.9 Cr |
 Aditya Birla Sun Life Multi-Cap FundAditya Birla Sun Life Mutual Fund | 19,22,125 | 0.67% | ₹48.7 Cr |
 UTI Healthcare FundUTI Mutual Fund | 11,76,815 | 2.09% | ₹29.8 Cr |
 ICICI Prudential Small Cap FundICICI Prudential Mutual Fund | 7,89,385 | 0.20% | ₹20.0 Cr |
| UTI Small Cap FundUTI Mutual Fund | 7,33,345 | 0.36% | ₹18.6 Cr |
| Aditya Birla Sun Life Pharma and Healthcare FundAditya Birla Sun Life Mutual Fund | 6,57,040 | 1.55% | ₹16.7 Cr |
Portfolios disclosed for Sep 2026. Weight is the holding as a share of the fund's assets.
Promoter and insider buying and selling
Trades made since 30 Oct 2025.Jupiter Life Line Hospitals insider trading
No promoter, director, key manager or employee bought or sold on the market.
- Others: no market trade
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Jupiter Life Line Hospitals competitors and peers
Hospital, 40 listed companies, priced on 29 Oct 2026. The table lists the 8 companies closest to Jupiter Life Line Hospitals in market cap.Healthcare companies
Jupiter Life Line Hospitals is not on the chart: it has no P/E or return on equity today
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Rainbow Childrens MedicareRAINBOW | 12,155 | 42.59 | 7.38 | +18.3% | +10.9% | 18.3% | 25.0% | 0.29% |
 Park Medi WorldPARKHOSPS | 9,556 | – | 4.73 | – | – | – | – | 0.00% |
 Yatharth Hospital & Trauma Care ServicesYATHARTH | 8,896 | 49.88 | 4.92 | +44.0% | – | 10.5% | 10.2% | 0.05% |
 Healthcare Global EnterprisesHCG | 8,830 | 387.64 | 6.63 | +13.8% | −38.6% | 2.0% | 9.6% | 0.00% |
| Paras HealthcarePARASHLTH | 8,387 | – | – | – | – | – | – | 0.00% |
 Kovai Medical Center & HospitalKOVAI | 6,452 | 25.17 | 4.89 | +15.0% | +16.3% | 21.3% | 20.3% | 0.25% |
 Artemis Medicare ServicesARTEMISMED | 4,717 | 41.50 | 5.05 | +15.0% | +30.3% | 12.8% | 13.2% | 0.15% |
 Indraprastha Medical CorporationINDRAMEDCO | 2,918 | 15.19 | 3.58 | +10.7% | +10.0% | 26.1% | 28.6% | 1.26% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Dividends
Per share, by the year it was paid for, and the latest payments.Jupiter Life Line Hospitals dividend history
Dividend per share, ₹, restated for later splits and bonuses
Dividend per share. The dividends declared for the year, each restated to today's share count by the splits and bonuses after its own ex-date, added up. Dividend per share in the glossaryHighest ₹0.20 a share, years to Mar 2024, Mar 2025 and Mar 2026.
| Ex-date | Type | Per share |
|---|---|---|
| 22 May 2026 | Interim | ₹1.00 |
| 4 Jul 2025 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. Final dividend in the glossary | ₹1.00 |
| 2 Aug 2024 | Final | ₹1.00 |
Latest payments, as declared, by ex-date.
Latest announcements
Routine notices left out.Jupiter Life Line Hospitals announcements
Oct 2026
23 Oct · Results
8 Oct · Analysts
Sep 2026
15 Sep · Analysts
Jupiter Life Line Hospitals share price by year
Each calendar year to 2025.Jupiter Life Line Hospitals share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 278.68 | −10.8% | 339.71 | 272.06 |
| 2024 | 312.56 | +43.4% | 319.83 | 211.23 |
| 2023 | 217.98 | – | 234.02 | 197.43 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2023 is from its first session, 18 Sep 2023.
Recent sessions
The 9 trading days to 28 Oct 2026, as traded on NSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 28 Oct 2026 | 255.90 | 259.80 | 252.15 | 256.75 | 257.07 | 38,443 | 43.5% |
| 27 Oct 2026 | 253.95 | 261.80 | 250.95 | 256.15 | 256.98 | 2,08,589 | 49.3% |
| 26 Oct 2026 | 248.65 | 259.35 | 243.55 | 252.95 | 252.55 | 2,85,444 | 34.6% |
| 23 Oct 2026 | 243.05 | 253.90 | 233.40 | 244.00 | 243.38 | 2,98,245 | 50.6% |
| 22 Oct 2026 | 243.00 | 245.70 | 240.00 | 243.05 | 242.43 | 68,941 | 54.2% |
| 21 Oct 2026 | 246.40 | 247.80 | 240.95 | 246.45 | 244.20 | 1,28,785 | 70.0% |
| 19 Oct 2026 | 247.00 | 249.90 | 242.20 | 243.90 | 245.20 | 65,751 | 55.4% |
| 16 Oct 2026 | 241.40 | 250.00 | 236.75 | 247.05 | 242.73 | 1,87,916 | 46.5% |
| 15 Oct 2026 | 243.20 | 244.80 | 234.95 | 239.65 | 239.52 | 2,99,803 | 62.5% |
Prices in ₹ per share as traded, not adjusted.
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Stock split history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 24 Jul 2026 | Split | 0.2000 | Each share became 5. |
Earlier prices are multiplied by the factor, so the chart reads as one share held throughout.
Company details
- NSE symbol
- JLHL
- BSE code
- 543980
- ISIN
- INE682M01020
- Industry
- Healthcare Services
- Website
- www.jupiterhospital.com
- CIN
- L85100MH2002PLC137908
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 2002
- Registered office
- 1004, 360 Degree Business Park, 10th Floor, Maharana Pratap Chowk , LBS Marg Mulund (West)-, Mumbai 400080, Maharashtra
- Share registrar
- KFin Technologies Ltd
- Keeps the register of shareholders and handles transfers and dividend payments